SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

NXTCL (NXTCL) News

Follow NXTCL (NXTCL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol NXTCL Asset market Sector Markets 90 days 3 Updated Aug 28, 2026, 09:19 AM UTC Open live news feed
L NextCell Pharma (Q2 review): Just ahead of Phase ll readout NextCell Pharma (Q2 review): Just ahead of Phase ll readout EQUITY | Aug 28, 2026, 09:19 AM UTC L Nextcell Pharma reports Q2 2026 operating income of SEK 3.0 mln Nextcell Pharma said Q2 2026 operating income was SEK 3.0 million. EARNINGS | Aug 27, 2026, 05:33 AM UTC L NXTCL reports operating income doubled; first commercial product launched NXTCL said operating income doubled and it launched its first commercial product, while awaiting pivotal clinical data. EQUITY | Aug 27, 2026, 05:32 AM UTC